Menu Back toExhibits

DIA/FDA Oligonucleotide-Based Therapeutics Conference

Convening industry and health authorities to inform, educate, and share advancements in oligonucleotide-based therapeutic product development.

Thank you for your interest in exhibiting with DIA at the Oligonucleotide-based Therapeutics Conference. The exhibit and marketing opportunities are now available.

Request Prospectus

Exhibiting Companies

  • CMIC, INC.
  • ChemGenes
  • Nitto Denko Avecia Inc.
  • Agilent Technologies, Inc.
  • Wave Life Sciences

Contact us

Customer Service


On-Demand Complimentary Webinar

Oligonucleotide-Based Therapeutics in Rare Diseases

Insights Guide to Oligonucleotide-Based Therapeutics

Download Guide